Literature DB >> 8158053

Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis.

P A Zimmerman1, R H Guderian, E Aruajo, L Elson, P Phadke, J Kubofcik, T B Nutman.   

Abstract

Definitive diagnosis of Onchocerca volvulus (Ov) infection requires the identification of the parasite in either the skin or subcutaneous nodules. These parasitologic approaches suffer from poor sensitivity. To assess the efficacy and utility of a polymerase chain reaction (PCR)-based diagnosis for Ov infection, skin snips were examined from 94 persons in an Ov-endemic region of Ecuador, and results were compared in a blinded fashion with those of a PCR assay based on the Onchocerca-specific repetitive DNA sequence, O-150. All 60 patients microfilaria-positive on skin snip examination were positive in the PCR-based assay. In addition, 13 of 34 who were microfilaria-negative by skin snips were positive in the PCR assay. This suggests that the PCR-based assay is significantly more sensitive than current methods and overcomes many deficiencies of parasitologic and serologic methodologies in diagnosing active onchocerciasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158053     DOI: 10.1093/infdis/169.3.686

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.

Authors:  P J Cooper; I Espinel; M Wieseman; W Paredes; M Espinel; R H Guderian; T B Nutman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 2.  Recent advances in tropical medicine.

Authors:  D N Lockwood; G Pasvol
Journal:  BMJ       Date:  1994-06-11

3.  Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.

Authors:  James S McCarthy; Moira Wieseman; Joe Tropea; David Kaslow; David Abraham; Sara Lustigman; Rocky Tuan; Ronald H Guderian; Thomas B Nutman
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Toward molecular parasitologic diagnosis: enhanced diagnostic sensitivity for filarial infections in mobile populations.

Authors:  Doran L Fink; Gary A Fahle; Steven Fischer; Daniel F Fedorko; Thomas B Nutman
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

5.  Insights Into Onchocerca volvulus Population Biology Through Multilocus Immunophenotyping.

Authors:  Carmelle T Norice-Tra; José Ribeiro; Sasisekhar Bennuru; Michael P Fay; Rahul Tyagi; Makedonka Mitreva; Thomas B Nutman
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

6.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Comparison between the skin snip test and simple dot blot assay as potential rapid assessment tools for Onchocerciasis in the postcontrol era in Ghana.

Authors:  G E Guzmán; K Awadzi; N Opoku; R B Narayanan; H O Akuffo
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

8.  Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan.

Authors:  Mario A Rodríguez-Pérez; Miguel A Lutzow-Steiner; Aldo Segura-Cabrera; Cristian Lizarazo-Ortega; Alfredo Domínguez-Vázquez; Mauricio Sauerbrey; Frank Richards; Thomas R Unnasch; Hassan K Hassan; Raymundo Hernández-Hernández
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

9.  [Onchocerciasis].

Authors:  C D Enk; K Gardlo; T Ruzicka; D BenEzra
Journal:  Hautarzt       Date:  2003-04-18       Impact factor: 0.751

10.  A 41-year-old woman from Cameroon with infertility.

Authors:  Larry W Chang; Megan E Reller; Justin A Bishop; Kawsar Talaat; Thomas B Nutman; Paul G Auwaerter
Journal:  Clin Infect Dis       Date:  2008-07-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.